The replication of β cells in normal physiology, in disease and for therapy

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 11, 2007, Pages 758-768

  Butler, Peter C ^a   Meier, Juris J ^a   Butler, Alexandra E ^a   Bhushan, Anil ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cell mass; cell regeneration; cell replication; Cell cycle; Diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GASTRIN; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GROWTH FACTOR; METFORMIN; NATEGLINIDE; RAMIPRIL; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA; TROGLITAZONE;

APOPTOSIS; B LYMPHOCYTE; CELL CYCLE; CELL CYCLE REGULATION; CELL DIVISION; CELL GROWTH; CELL REGENERATION; DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOLYSIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS;

EID: 35448986170     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0647     Document Type: Review

References (84)

1. Meier JJ and Butler PC (2005) Insulin secretion. In Endocrinology, edn 5, 961-973 (Eds DeGroot LJ and Jameson JL) Philadelphia: Elsevier Saunders
2. Stefan Y et al. (1982) Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes 31: 694-700
3. Service FJ (1999) Classification of hypoglycemic disorders. Endocrinol Metab Clin North Am 28: 501-517, vi
4. Stanger BZ et al. (2007) Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 445: 886-891
5. Georgia S et al. (2006) p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol 298: 22-31
6. Kassem SA et al. (2000) β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49: 1325-1333
7. Dor Y et al. (2004) Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46
8. Teta M et al. (2007) Growth and regeneration of adult β cells does not involve specialized progenitors. Dev Cell 12: 817-826
9. Rane SG et al. (1999) Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat Genet 22: 44-52
10. Georgia S et al. (2004) β Cell replication is the primary mechanism for maintaining postnatal β cell mass. J Clin Invest 114: 963-968
11. Kushner JA et al. (2005) Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol Cell Biol 25: 3752-3762
12. Vasavada RC et al. (2007) Tissue-specific deletion of the retinoblastoma protein in the pancreatic β-cell has limited effects on β-cell replication, mass, and function. Diabetes 56: 57-64
13. Krishnamurthy J et al. (2006) p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443: 453-457
14. Uchida T et al. (2005) Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11: 175-182
15. Georgia S et al. (2006) p27 Regulates the transition of β-cells from quiescence to proliferation. Diabetes 55: 2950-2956
16. Karnik SK et al. (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci USA 102: 14659-14664
17. Teta M et al. (2005) Very slow turnover of β-cells in aged adult mice. Diabetes 54: 2557-2567
18. Van Assche FA et al. (1978) A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 85: 818-820
19. Butler AE et al. (2003) β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110
20. Terauchi Y et al. (2007) Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 117: 246-257
21. Okamoto H et al. (2006) Role of the forkhead protein FoxO1 in β cell compensation to insulin resistance. J Clin Invest 116: 775-782
22. Kulkarni RN et al. (2004) PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114: 828-836
23. Gupta RK et al. (2007) Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev 21: 756-769
24. Cozar-Castellano I et al. (2006) Molecular control of cell cycle progression in the pancreatic β-cell. Endocr Rev 27: 356-370
25. Bannigan J et al. (1979) The cellular effect of 5-bromodeoxyuridine on the mammalian embryo. J Embryol Exp Morphol 50: 123-135
26. Beisker W et al. (1988) Measurement of the kinetics of DNA repair synthesis after UV irradiation using immunochemical staining of incorporated 5-bromo-2′-deoxyuridine and flow cytometry. Exp Cell Res 174: 156-167
27. Endl E et al. (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257: 231-237
28. Zacchetti A et al. (2003) Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxyuridine labelling by immunohistochemistry. APMIS 111: 430-438
29. Bullwinkel J et al. (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206: 624-635
30. Hendzel MJ et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106: 348-360
31. Butler AE et al. (2003) Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52: 2304-2314
32. Ianus A et al. (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850
33. Bonner-Weir S et al. (2002) Pancreatic stem cells. J Pathol 197: 519-526
34. Gershengorn MC et al. (2004) Epithelial-tomesenchymal transition generates proliferative human islet precursor cells. Science 306: 2261-2264
35. Butler AE et al. (2007) Hematopoietic stem cells derived from adult donors are not a source of pancreatic β cells in adult nondiabetic humans. Diabetes 56: 1810-1806
36. Kayali AG et al. (2007) Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-producing β-cells. Diabetes 56: 703-708
37. Hess D et al. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21: 763-770
38. Voltarelli JC et al. (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297: 1568-1576
39. Atkinson MA (2005) ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54: 1253-1263
40. Foulis AK et al. (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26: 456-461
41. Meier JJ et al. (2006) Increased islet β cell replication adjacent to intrapancreatic gastrinomas in humans. Diabetologia 49: 2689-2696
42. Meier JJ et al. (2005) Sustained β cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48: 2221-2228
43. Sit KH et al. (1997) Transient G2M arrest and subsequent release of apoptotic and mitotic cells in vanadyl(4)-prepulsed human Chang liver cells. Cell Death Differ 4: 216-223
44. Webb SJ et al. (1997) Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol 41: 1-34
45. Ritzel RA et al. (2003) Replication increases β-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52: 1701-1708
46. Sladek R et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885
47. Zeggini E et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341
48. Scott LJ et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345
49. Bort R et al. (2004) Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 131: 797-806
50. Stickens D et al. (1996) The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet 14: 25-32
51. Spagnoli FM et al. (2006) The RNA-binding protein, Vg1RBP, is required for pancreatic fate specification. Dev Biol 292: 442-456
52. Saxena R et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55: 2890-2895
53. Ubeda M et al. (2006) Inhibition of cyclin-dependent kinase 5 activity protects pancreatic β cells from glucotoxicity. J Biol Chem 281: 28858-28864
54. Ritzel RA et al. (2006) Relationship between β-cell mass and fasting blood glucose concentration in humans. Diabetes Care 29: 717-718
55. Barker DJ et al. (1993) Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67
56. de Rooij SR et al. (2006) Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia 49: 637-643
57. Fakhrai-Rad H et al. (2000) Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum Mol Genet 9: 2149-2158
58. Nath DS et al. (2005) Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant 19: 792-797
59. Robertson RP et al. (1999) Normoglycemia and preserved insulin secretory reserve in diabetic patients 10-18 years after pancreas transplantation. Diabetes 48: 1737-1740
60. Bonner-Weir S et al. (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71: 1544-1553
61. Bonner-Weir S (1994) Regulation of pancreatic β-cell mass in vivo. Recent Prog Horm Res 49: 91-104
62. Robertson RP et al. (2002) Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73: 736-741
63. Matveyenko AV et al. (2006) Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55: 2347-2356
64. Stagner JI et al. (1991) Deterioration of islet β-cell function after hemipancreatectomy in dogs. Diabetes 40: 1472-1479
65. Meier JJ et al. (2006) Direct evidence of attempted β cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49: 1838-1844
66. Meier JJ et al. (2006) The potential for stem cell therapy in diabetes. Pediatr Res 59: 65R-73R
67. Meier JJ et al. (2006) Increased vulnerability of newly forming β cells to cytokine-induced cell death. Diabetologia 49: 83-89
68. Herold KC et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346: 1692-1698
69. Leslie RD (2004) Preventing type 1 diabetes mellitus: hype and hope. Clin Med 4: 442-446
70. Buchanan TA et al. (2002) Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 51: 2796-2803
71. Suarez-Pinzon WL et al. (2005) Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54: 2596-2601
72. Rhodes CJ (2000) IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24: 303-311
73. Meier JJ et al. (2005) Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21: 91-117
74. Marchetti P et al. (2004) Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89: 5535-5541
75. (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 854-865
76. Kahn SE et al. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355: 2427-2443
77. Lin CY et al. (2005) Activation of peroxisome proliferator- activated receptor-γ by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 90: 6678-6686
78. Nissen SE et al. (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356: 2457-2471
79. Matthews DR et al. (1998) UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15: 297-303
80. Maedler K et al. (2005) Sulfonylurea induced β-cell apoptosis in cultured human islets. J Clin Endocrinol Metab 90: 501-506
81. Lupi R et al. (2006) The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J Endocrinol 154: 355-361
82. Bosch J et al. (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355: 1551-1562
83. Kjems LL et al. (2001) Decrease in β-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. Diabetes 50: 2001-2012
84. Matveyenko AV et al. (2006) β-Cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55: 2106-2114